Literature DB >> 19694603

Hypersensitivity reaction to ranitidine: description of a case and review of the literature.

Caterina Foti1, Nicoletta Cassano, Rosanna Panebianco, Gian Franco Calogiuri, Gino A Vena.   

Abstract

Ranitidine is an H2-receptor antagonist which is usually well tolerated. Hypersensitivity reactions to ranitidine, as well as other H2 antihistamines, have been rarely described. We report the case of a 47-year-old woman who developed an anaphylactic reaction to ranitidine used as intravenous premedication before anesthesia induction. The patient's history revealed that previous use of oral ranitidine for a peptic ulcer disease did not cause any adverse reaction. Intradermal test with ranitidine at a dilution of 1:100 gave an intense positive reaction. The protective role of H2-receptor antagonists as premedication is still unclear and should be carefully reconsidered on the basis of the available controversial evidence and the possible risk of hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694603     DOI: 10.1080/08923970902739078

Source DB:  PubMed          Journal:  Immunopharmacol Immunotoxicol        ISSN: 0892-3973            Impact factor:   2.730


  3 in total

1.  Is antihistaminergic H2 really useful in prevention of hypersensitivity induced by paclitaxel?

Authors:  Florian Slimano; Pierre Coliat; Jeanne-Marie Perotin; Juliette Vella-Boucaud; Céline Mongaret; Olivier Bouché
Journal:  Support Care Cancer       Date:  2016-08-01       Impact factor: 3.603

2.  World allergy organization guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Yehia M El-Gamal; Dennis K Ledford; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong
Journal:  World Allergy Organ J       Date:  2011-02-23       Impact factor: 4.084

3.  Ranitidine and the incidence of hypersensitivity reactions to paclitaxel: A retrospective cohort study.

Authors:  Anouk I Haine; Cornelia Marije A W Notenboom; Liong Vincent P Tan; Rikje Ruiter; Wendy M van der Deure
Journal:  Pharmacol Res Perspect       Date:  2022-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.